BioSpace News Archive

Immutep Limited (ASX: IMM; NASDAQ: IMMP) announces new interim data from its ongoing Phase II TACTI-002 study

AstraZeneca has entered into an agreement with Dogma Therapeutics to acquire its preclinical oral PCSK9 inhibitor programme.

Humanigen, Inc. (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate lenzilumab, announced today that it has priced its underwritten public offering of 8,000,000 shares of common stock at a public offering price of $8.50 per share,

Eisai Co., Ltd. announced today that it has established a new pharmaceutical sales subsidiary in Ho Chi Minh City, the Socialist Republic of Viet Nam (Vietnam), which will be named Eisai Vietnam Co., Ltd. (Eisai Vietnam). Eisai Vietnam is a wholly-owned subsidiary of Eisai.

With a combined COVID-19/ flu season approaching, the Patient Safety Authority is warning Pennsylvanians about another, even deadlier condition.

THINK Surgical®, Inc., an advanced orthopedic robot technology company, announced the official launch of its new corporate website www.thinksurgical.com.

Real Time Medical Systems (Real Time), the leading post-acute interventional analytics platform, today announced the appointment of Steven M. Stein, MD as Chief Medical Officer.

Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences submitted their findings to ACS Nano, a monthly peer-reviewed scientific journal, on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SARS-CoV-2 Spike proteins and human cells.

United Spinal Association was instrumental in championing a resolution that passed the U.S. Senate designating September 2020 as National Spinal Cord Injury Awareness Month.

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the promotion of Drew Hykes to Chief Operating Officer, effective September 1, 2020